Device Off-Label Data Dissemination Must Include Package Insert Data - FDA
This article was originally published in The Gray Sheet
Information disseminated by manufacturers regarding unapproved uses of marketed devices must include the same information generally found in package inserts, FDA says in a proposed rule published in the June 8 Federal Register.
You may also be interested in...
Major generics companies have donated hydroxychloroquine sulfate doses for research and treatment of coronavirus. Companies are also donating hand sanitizer and personal protective equipment and are preparing to ramp up manufacturing and production.
Inovio forges ahead into Phase I trials with DNA-based vaccine candidate, but can it prove skeptics wrong?
Erectile dysfunction drug sildenafil, plus treatments for skin conditions such as eczema, are among a bounty of Rx-to-OTC switches approved in Switzerland.